Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
Unicycive Therapeutics Inc. Common Stock
UNCY | US
0.43
USD0.01
1.33%
UNCY | US
About Unicycive Therapeutics Inc. Common Stock
Sector
Healthcare
Industry
Biotechnology
Earnings date
30/06/2024
As of date
21/10/2024
Close
0.43
Open
0.43
High
0.45
Low
0.42
Unicycive Therapeutics Inc. a biotechnology company engages in developing novel therapies for kidney diseases in the United States. It is developing Renazorb for treatment of hyperphosphatemia in patients with chronic kidney disease on dialysis; and UNI 494 which is in Phase 1 clinical trials for treatment of acute kidney injury. The company was incorporated in 2016 and is based in Los Altos California.
View LessUNCY | US
Risk
70.4
Sharpe
-0.46
Luna's Score
43/100
Recommendation
Sell
Luna says (UNCY | US)
What's Working
Low Debt to Equity (< 0.25)
What's not Working
High 6-Month Volatility (>65%)
Microcap (<300M USD)
High Market Beta (> 0.8)
Weak Sharpe Ratio (< 0.3)
Volatility Signals
Bearish: Increased Volatility (6-month > 1-month volatility)
Risk Meter
10 days
70.6%1 month
70.4%3 months
124.8%6 months
121.0%Returns
Fundamental Ratios
PE
-
Fwd. PE
-
Price to book
4.89
Debt to equity
-3.15
Debt to assets
1.05
Ent. to EBITDA
-1.03
Ent. to rev.
47.00
PEG
-
Other Fundamentals
EBITDA
-28.84M
MarketCap
41.02M
MarketCap(USD)
41.02M
Div. yield
-
Op. margin
-
Erngs. growth
-
Rev. growth
-
Ret. on equity
-121.76
Short ratio
0.60
Short perc.
1.14
Market Sentiment (SMA and Price signals)
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bullish (SMA1M > SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
SMAs: Stock Price Trends
Range10D
0.13
Range1M
0.14
Range3M
0.30
Volumes: Market Activity
Rel. volume
0.77
Price X volume
445.36K
Peers
Diversifiers
Industry Comparison
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | -1.03 | 0.53 | Cheaper |
| Ent. to Revenue | 47.00 | 3,967.00 | Cheaper |
| PE Ratio | - | 41.03 | - |
| Price to Book | 4.89 | 15.55 | Cheaper |
| Dividend Yield | - | 2.20 | - |
| Std. Deviation (3M) | 124.84 | 72.80 | Riskier |
| Debt to Equity | -3.15 | -1.23 | Cheaper |
| Debt to Assets | 1.05 | 0.25 | Expensive |
| Market Cap | 41.02M | 3.66B | Emerging |
